"Drug dosing in the intensive care unit: the critically ill are a special population too".
Murray
Patrick T
PT
D000925:Anticoagulants / Q000008:administration & dosage*; D001120:Arginine / Q000031:analogs & derivatives; D016638:Critical Illness; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D007362:Intensive Care Units; D010875:Pipecolic Acids / Q000008:administration & dosage*; D051437:Renal Insufficiency / Q000503:physiopathology / Q000628:therapy; D017582:Renal Replacement Therapy; D013449:Sulfonamides; D013921:Thrombocytopenia / Q000139:chemically induced
D000925:Anticoagulants; D010875:Pipecolic Acids; D013449:Sulfonamides; D006493:Heparin; D001120:Arginine; C031942:argatroban